China Traditional Chinese Medicine Holdings
Launch date
Employees
Market cap
$2.6b
Enterprise valuation
$2.8b (Public information from Sep 2024)
Share price
HKD4.35 0570.HK
Wan Chai District Hong Kong Island (HQ)
Financials
Estimates*
| CNY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 14.8b | 19.1b | 14.3b | 18.1b | 20.0b | 22.5b | 26.1b |
| % growth | 3 % | 29 % | (25 %) | 27 % | 10 % | 12 % | 16 % |
| EBITDA | 3.2b | 3.6b | 2.3b | 2.6b | 2.8b | 3.2b | 3.6b |
| % EBITDA margin | 22 % | 19 % | 16 % | 14 % | 14 % | 14 % | 14 % |
| Profit | 1.7b | 1.9b | 764m | 1.3b | 1.4b | 1.5b | 1.8b |
| % profit margin | 11 % | 10 % | 5 % | 7 % | 7 % | 7 % | 7 % |
| EV / revenue | 1.0x | 1.1x | 1.0x | 1.1x | 0.7x | 0.8x | 0.4x |
| EV / EBITDA | 4.6x | 5.6x | 6.3x | 7.5x | 4.7x | 5.3x | 3.0x |
| R&D budget | 550m | 694m | 612m | 686m | - | - | - |
| R&D % of revenue | 4 % | 4 % | 4 % | 4 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
